Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
12/2003
12/31/2003WO2004000367A1 Ace2 activation for treatment of heart, lung and kidney disease and hypertension
12/31/2003WO2004000366A1 Pegylated factor vii glycoforms
12/31/2003WO2004000349A1 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation
12/31/2003WO2004000233A2 Algal gdp-mannose-3',5'-epimerases and methods of use thereof
12/31/2003WO2004000008A1 A method for increasing resistance of monocot plants against abiotic stresses
12/31/2003WO2003076633A3 Inhibition of germination in plants
12/31/2003WO2003074676A3 Wax ester synthase dna sequence, protein and uses thereof
12/31/2003WO2003065795A3 An invertebrate animal model with neurodegenerative phenotype for screening and testing substances
12/31/2003WO2003064638A3 Elongase gene and method for producing polyunsaturated fatty acids
12/31/2003WO2003064465A3 Prkag3 gene promoter and uses thereof
12/31/2003WO2003056036A3 Genes
12/31/2003WO2003048310A3 Thermus oshimai nucleic acid polymerases
12/31/2003WO2003035844A3 Novel histone methyltransferase and methods of its use
12/31/2003WO2003033667A3 Use of mx gtpases in the prognosis and treatment of cancer
12/31/2003WO2003023035A3 Glucosyltransferases which glucosylate abscisic acid
12/31/2003WO2003020759A9 A caspase- 8 binding protein, its preparation and use
12/31/2003WO2003010286A9 Nucleic acids, polypeptides, and methods for modulating apoptosis
12/31/2003WO2003000912A8 A process for the preparation of gallic acid by co-culture
12/31/2003WO2002097059B1 Chromosome-based platforms
12/31/2003WO2002079381A3 Biosynthesis of s-adenosylmethionine in a recombinant yeast strain
12/31/2003WO2002077220A3 Nucleic acids encoding human est1 proteins
12/31/2003WO2002064796A3 Butyrylcholinesterase polypeptide variants with increased catalytic efficiency and methods of use
12/31/2003WO2002064764A3 Terpene synthase/cyclase and olefin synthase and uses thereof
12/31/2003WO2002047708A3 Selective cox-2 inhibition from edible plant extracts
12/31/2003WO2002042444A3 Fungal gene cluster associated with pathogenesis
12/31/2003WO2002042325A3 Cyp1b1 nucleic acids and methods of use
12/31/2003WO2002042320A3 Haplotypes of the gsr gene
12/31/2003WO2002040650A3 Methods for large scale production of recombinant dna-derived tpa or k2s molecules
12/31/2003CN1464055A A novel penicillin G acylase and use thereof
12/31/2003CN1464054A Process for extracting lysozyme from eggs and bird eggs
12/31/2003CN1464053A New polypeptide-Glycosyl 12 and polynucleotides for coding same
12/31/2003CN1464052A New polypeptide-human RNA uncoiling enzyme 95 and polynucleotides for coding same
12/31/2003CN1464051A Herpesvirus thymine deoxyriboside kinase mutant and use thereof
12/31/2003CN1464050A Process for extracting superoxide dismutase from fresh animal blood
12/31/2003CN1464049A New polypeptide-human sailer transposase 11 and polynucleotides for coding same
12/31/2003CN1463781A Process for extracting inner cell product using cytoclasis and double aqueous phase extraction technology
12/31/2003CN1132939C Coding sequence of pyrophosphate synthetase, its encoded polypeptide and its preparing process
12/31/2003CN1132938C Process for producing trans-4-hydroxy-L-proline
12/31/2003CN1132929C Enzyme method preparation for high-purity oligoxylose
12/31/2003CA2740137A1 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids
12/31/2003CA2530108A1 Oligonucleotide inhibitors of mbd2/dna demethylase and uses thereof
12/31/2003CA2491803A1 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders
12/31/2003CA2490771A1 Thioesterase-related nucleic acid sequences and methods
12/31/2003CA2490360A1 Pegylated factor vii glycoforms
12/31/2003CA2490195A1 A non-blended soybean oil with high oleic acid content
12/31/2003CA2490006A1 Nematode phosphoethanolamine n-methyltransferase-like sequences
12/31/2003CA2490004A1 Plastid division and related genes and proteins, and methods of use
12/31/2003CA2489873A1 Ace2 activation for treatment of hypertension, heart, lung and kidney disease
12/31/2003CA2489617A1 Novel acetylcholinesterase gene responsible for insecticide resistance and applications thereof
12/31/2003CA2489533A1 Plastidial targeting peptide
12/31/2003CA2489024A1 Use of pp2a phosphatase modulators in the treatment of mental disorders
12/31/2003CA2480892A1 Novel promoter
12/30/2003US6670527 Gibberellin 2-oxidase
12/30/2003US6670525 Transgenic plants and cells with altered degree of amylopectin branching
12/30/2003US6670467 Nucleotide sequences for tissue-independent or constitutive promoters for genes encoding actin-2, enolase, Gos-2 and L41
12/30/2003US6670455 Use of a chromatography separation processes and/or fractional precipitation
12/30/2003US6670449 Hybrid molecules and their use for optically detecting changes in cellular microenvironments
12/30/2003US6670342 Method of treating hepatitis delta virus infection
12/30/2003US6670189 Fumonisin detoxification compositions and methods
12/30/2003US6670187 Mutant Plk protein and gene encoding the same
12/30/2003US6670168 Recombinant Streptomyces hygroscopicus host cells that produce 17-desmethylrapamycin
12/30/2003US6670167 Catalytic domain of the human effector cell cycle checkpoint protein kinase materials and methods for identification of inhibitors thereof
12/30/2003US6670166 Arthropod protein disulfide isomerases
12/30/2003US6670165 Generation preferential hydrolase; obtain sample containing hydrolase, incubate with phosphotransferase, recover hydrolase
12/30/2003US6670164 Isolated human kinase proteins
12/30/2003US6670163 Isolated human kinase proteins
12/30/2003US6670162 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
12/30/2003US6670161 Full-length human DNA polymerase-alpha catalytic polypeptide subunit having a specific amino acid sequence; has polymerase activity and wherein said composition lacks primase activity.
12/30/2003US6670160 Enzymatic polypeptide; for the diagnosis and detection of mammalian tumors
12/30/2003US6670159 Preparing monomeric metal ion chelator containing diacetyl glycine group linked to proteinaceous molecule
12/30/2003US6670157 Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use
12/30/2003US6670156 Polynucleotide encoding a diaminopimelate epimerase from Corynebacterium glutamicum
12/30/2003US6670147 Nucleic acid construct for expressing active substances which can be activated by proteases, and preparation and use
12/30/2003US6670143 Polypeptides having lysophosphatidic acid acyltransferase activity and polynucleotides encoding polypeptides having LPAAT activity
12/30/2003US6670136 Peptide for use in the treatment of inflammation defects
12/30/2003US6669963 Stable particle in liquid formulations
12/30/2003US6669946 Therapy; diagnosis; T cells recognize and interact with complexes of cell surface molecules such as human leukocyte antigens or major histocompatibility complexes
12/30/2003CA2380690C Human osteoclast-derived cathepsin
12/30/2003CA2296070C Novel mapk kinase
12/30/2003CA2121358C Thymidine phosphorylase for use in the modulation of cellular proliferation or chemotaxis
12/30/2003CA2067862C Stable pura vectors and uses thereof
12/25/2003US20030237117 High velocity projectile bombardment; insect resistant plants
12/25/2003US20030237108 Compositions isolated from forage grasses and methods for their use
12/25/2003US20030237107 Nucleotide sequences; transfer cassettes; controlling gene expression; insertion of transfer cassettes
12/25/2003US20030236402 A caspase-3 enzyme inhibitors, 3-(3-alkyl-amino-2-oxo-1,2-dihydro-1-pyrazinyl-alkanoylamino) -4-oxopentanoic acid; treating cardiac or cerebral ischemia or reperfusion injury, diabetes, AIDS
12/25/2003US20030236242 Viricides
12/25/2003US20030236215 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
12/25/2003US20030236213 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/25/2003US20030236212 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/25/2003US20030235902 Dna; transformed culture product; heat treatment
12/25/2003US20030235901 Detoxification using amylase; drug screening analysis
12/25/2003US20030235900 Anticancer agents
12/25/2003US20030235899 Catalytic domain of the human effector cell cycle checkpoint protein kinase Chk1 materials and methods for identification of inhibitors thereof
12/25/2003US20030235898 Nematode GS-like sequences
12/25/2003US20030235897 Immunological control of beta-amyloid levels in vivo
12/25/2003US20030235894 Enzyme isomerization of galactose; fermentation; extraction; isomerization
12/25/2003US20030235893 Genetic engineered nucleic acids
12/25/2003US20030235884 Hybrid protein; process control; glycosylation
12/25/2003US20030235880 Genetic engineered nucleic acid
12/25/2003US20030235874 Expression vector comprising prostate specific enhancer sequences (PSES) and coding antiproliferative/antitumor agent for treatment of androgen-independent and androgen-dependent prostate carcinomas